Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Paul Olivier

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Frontiers in Cellular and Infection Microbiology|September 29, 2022
Dengue activates mTORC2 signaling to counteract apoptosis and maximize viral replicationChristoph C Carter, Fred D Mast, Jean Paul Olivier, et al.
Bio-Protocol|March 12, 2026
High-Resolution Quantification of Two-Way Nanobody Synergy Using Automated Liquid Handling and Computational ModelingNatasha M Bourgeois, Satchel W Bell, Jean Paul Olivier, et al.
Biorxiv : the Preprint Server for Biology|July 28, 2023
Nanobody repertoire generated against the spike protein of ancestral SARS-CoV-2 remains efficacious against the rapidly evolving virusNatalia E Ketaren, Fred D Mast, Peter C Fridy, et al.
Elife|May 7, 2024
Nanobody repertoire generated against the spike protein of ancestral SARS-CoV-2 remains efficacious against the rapidly evolving virusNatalia E Ketaren, Fred D Mast, Peter C Fridy, et al.
Biorxiv : the Preprint Server for Biology|November 11, 2020
Viral protein engagement of GBF1 induces host cell vulnerability through synthetic lethalityArti T Navare, Fred D Mast, Jean Paul Olivier, et al.
The Journal of Cell Biology|October 28, 2022
Viral protein engagement of GBF1 induces host cell vulnerability through synthetic lethalityArti T Navare, Fred D Mast, Jean Paul Olivier, et al.
Biorxiv : the Preprint Server for Biology|April 14, 2021
Nanobody Repertoires for Exposing Vulnerabilities of SARS-CoV-2Fred D Mast, Peter C Fridy, Natalia E Ketaren, et al.
Elife|December 7, 2021
Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escapeFred D Mast, Peter C Fridy, Natalia E Ketaren, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Frontiers in Cellular and Infection Microbiology|September 29, 2022
Dengue activates mTORC2 signaling to counteract apoptosis and maximize viral replicationChristoph C Carter, Fred D Mast, Jean Paul Olivier, et al.
Bio-Protocol|March 12, 2026
High-Resolution Quantification of Two-Way Nanobody Synergy Using Automated Liquid Handling and Computational ModelingNatasha M Bourgeois, Satchel W Bell, Jean Paul Olivier, et al.
Biorxiv : the Preprint Server for Biology|July 28, 2023
Nanobody repertoire generated against the spike protein of ancestral SARS-CoV-2 remains efficacious against the rapidly evolving virusNatalia E Ketaren, Fred D Mast, Peter C Fridy, et al.
Elife|May 7, 2024
Nanobody repertoire generated against the spike protein of ancestral SARS-CoV-2 remains efficacious against the rapidly evolving virusNatalia E Ketaren, Fred D Mast, Peter C Fridy, et al.
Biorxiv : the Preprint Server for Biology|November 11, 2020
Viral protein engagement of GBF1 induces host cell vulnerability through synthetic lethalityArti T Navare, Fred D Mast, Jean Paul Olivier, et al.
The Journal of Cell Biology|October 28, 2022
Viral protein engagement of GBF1 induces host cell vulnerability through synthetic lethalityArti T Navare, Fred D Mast, Jean Paul Olivier, et al.
Biorxiv : the Preprint Server for Biology|April 14, 2021
Nanobody Repertoires for Exposing Vulnerabilities of SARS-CoV-2Fred D Mast, Peter C Fridy, Natalia E Ketaren, et al.
Elife|December 7, 2021
Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escapeFred D Mast, Peter C Fridy, Natalia E Ketaren, et al.
Pageof 1